跳至主要内容
临床试验/DRKS00027805
DRKS00027805已完成不适用

Evaluation of risk factors for the development of diabetic retinopathy (DR) in patients with type 2 diabetes: comprehensive analysis with optical coherence tomography (OCT), VEGF and biomarkers of inflammation - OCT-VEGF II

GWT TUD GmbH0 个研究点目标入组 32 人开始时间: 2022年1月18日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
GWT TUD GmbH
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Written informed consent
  • Patients with type 2 diabetes mellitus (T2DM) for whom datasets from the previous studies are available
  • Ability to understand and follow study-related instructions

排除标准

  • Acute infection within 14 days prior to screening
  • Acute inflammatory disease within 14 days prior to screening or current chronic inflammatory disease
  • Pre-existing autoimmune disease
  • Treatment with immune suppressive drugs within 14 days prior to screening
  • Systemic treatment with glucocorticoids within 14 days prior to screening
  • Myocardial infarction or stroke within 1 year before inclusion
  • Surgeries (including intravitreal injections) within the previous 3 months
  • Oncological disease within the previous 5 years
  • Women who are pregnant or breast-feeding

研究者

发起方
GWT TUD GmbH

相似试验